Genmab — September 2020
-
Øget konkurrence i cervical https://finance.yahoo.com/news/agenus-presents-results-two-large-070000762.html
-
INNOVATV 208: NEW WEEKLY DOSING COHORT IN THE PHASE II STUDY OF TISOTUMAB VEDOTIN IN PLATINUM-RESISTANT OVARIAN CANCER https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/innovatv-208-new-weekly-dosing-cohort-in-the-phase-ii-study-of-tisotumab-vedotin-in-platinum-resistant-ovarian-cancer
-
Good results appear in PD-1 https://finance.yahoo.com/news/imfinzi-demonstrated-unprecedented-survival-unresectable-110000375.html
-
Cervical ... og Agenus arbejder hurtigt https://finance.yahoo.com/news/agenus-initiates-rolling-bla-submission-123000062.html
-
Aktieugebrevet: Køb/Salg
Handel i porteføljen (Køb/Salg): Køb
Aktie: Genmab
Kurs: 2421,00
Antal handlede aktier: 26
Andel i procent: Øges fra 0% til 5%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
